84 related articles for article (PubMed ID: 26307155)
1. Varicella-Zoster Immunity in US Healthcare Personnel With Self-Reported History of Disease.
Troiani L; Hill JJ; Consoli S; Weber DJ
Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1467-8. PubMed ID: 26307155
[No Abstract] [Full Text] [Related]
2. Screening healthcare workers for varicella-zoster virus: can we trust the history?
Almuneef M; Memish ZA; Abbas ME; Balkhy HH
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):595-8. PubMed ID: 15301033
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella.
De Juanes JR; Gil A; San-Martín M; González A; Esteban J; García de Codes A
Vaccine; 2005 Feb; 23(12):1434-6. PubMed ID: 15670877
[TBL] [Abstract][Full Text] [Related]
4. A history of infection with varicella is strongly predictive of the presence of varicella-zoster virus antibodies in a heterogenous Australian HIV cohort.
Gurry GA; Dendle C; Korman TM; Giles ML; Williams JH; Woolley IJ
AIDS; 2015 Sep; 29(15):2062-4. PubMed ID: 26352884
[No Abstract] [Full Text] [Related]
5. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.
Anugulruengkitt S; Puthanakit T; Siengboon S; Paitoonpong L; Kowitdamrong E; Pancharoen C; Pichitchok Y
Jpn J Infect Dis; 2017 Mar; 70(2):216-218. PubMed ID: 27580582
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
8. Varicella seroprevalence among health care workers in Korea: validity of self-reported history and cost-effectiveness of prevaccination screening.
Kang JH; Park YS; Park SY; Kim SB; Ko KP; Seo YH
Am J Infect Control; 2014 Aug; 42(8):885-7. PubMed ID: 25087140
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immunity to varicella-zoster virus: an overview.
Arvin AM
J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
[No Abstract] [Full Text] [Related]
10. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
[TBL] [Abstract][Full Text] [Related]
11. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
12. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
[TBL] [Abstract][Full Text] [Related]
14. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
Chazan B; Colodner R; Teitler N; Chen Y; Raz R
Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
[TBL] [Abstract][Full Text] [Related]
15. Varicella seroprevalence among health care workers.
Tin SS; Wiwanitkit V
Am J Infect Control; 2015 Feb; 43(2):196-7. PubMed ID: 25541336
[No Abstract] [Full Text] [Related]
16. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
17. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
19. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.
Asano Y; Takahashi M
Biken J; 1978 Mar; 21(1):15-23. PubMed ID: 208504
[No Abstract] [Full Text] [Related]
20. Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers.
Qureshi M; Gordon SM; Yen-Lieberman B; Litaker DG
Infect Control Hosp Epidemiol; 1999 Jul; 20(7):516-8. PubMed ID: 10432167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
